Li GF - Search Results

1

Overall Mortality and Cardiovascular Mortality Associated With MAFLD+/NAFLD- Versus MAFLD-/NAFLD+: A Secondary Analysis.

Gao G, Guan AJ, Li GF, Yu G. Gao G, et al. Among authors: li gf. Liver Int. 2024 Nov 18. doi: 10.1111/liv.16118. Online ahead of print. Liver Int. 2024. PMID: 39555700 No abstract available.

2

Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in the Chinese population: opportunities and challenges.

Li GF, Yu G, Liu HX, Zheng QS. Li GF, et al. Clin Pharmacokinet. 2014 Feb;53(2):197-202. doi: 10.1007/s40262-013-0119-9. Clin Pharmacokinet. 2014. PMID: 24255013 No abstract available.

3

Yu G, Zheng QS, Li GF. Yu G, et al. Among authors: li gf. AAPS J. 2014 Nov;16(6):1162-6. doi: 10.1208/s12248-014-9652-1. Epub 2014 Sep 3. AAPS J. 2014. PMID: 25182208 Free PMC article. Review.

4

Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye.

Yu G, Zheng QS, Wang DX, Zhou HH, Li GF. Yu G, et al. Among authors: li gf. Lancet Oncol. 2014 Oct;15(11):e469-70. doi: 10.1016/S1470-2045(14)70458-9. Lancet Oncol. 2014. PMID: 25281461 No abstract available.

5

Comment on: "A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood".

Li GF, Gu X, Yu G, Zhao SY, Zheng QS. Li GF, et al. Clin Pharmacokinet. 2016 Jan;55(1):133-7. doi: 10.1007/s40262-015-0348-1. Clin Pharmacokinet. 2016. PMID: 26649873 No abstract available.

6

The role of a meal on gastrointestinal toxicity and maximum tolerated dose.

Yu G, Wang DX, Li GF, Zhou HH. Yu G, et al. Among authors: li gf. Lancet Oncol. 2016 Jan;17(1):e2-3. doi: 10.1016/S1470-2045(15)00552-5. Epub 2015 Dec 23. Lancet Oncol. 2016. PMID: 26758756 No abstract available.

7

Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition.

Yu G, Li GF, Markowitz JS. Yu G, et al. Among authors: li gf. J Child Adolesc Psychopharmacol. 2016 May;26(4):314-26. doi: 10.1089/cap.2015.0137. Epub 2016 Feb 9. J Child Adolesc Psychopharmacol. 2016. PMID: 26859445 Free PMC article. Review.

8

Fasting conditions in clinical oncology trials and drug labelling.

Yu G, Li GF, Wang DX, Wang J, Zhou HH. Yu G, et al. Among authors: li gf. Lancet Oncol. 2017 Sep;18(9):e506. doi: 10.1016/S1470-2045(17)30585-5. Lancet Oncol. 2017. PMID: 28884694 No abstract available.

9

Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.

Li GF, Yu G, Gong Y. Li GF, et al. JAMA Oncol. 2018 Feb 1;4(2):264. doi: 10.1001/jamaoncol.2017.3407. JAMA Oncol. 2018. PMID: 29098270 No abstract available.

10

Proton-pump inhibitors and glecaprevir plus pibrentasvir in HCV infection.

Yu G, Li GF, Zhou HH. Yu G, et al. Among authors: li gf. Lancet Infect Dis. 2017 Dec;17(12):1239-1240. doi: 10.1016/S1473-3099(17)30643-6. Lancet Infect Dis. 2017. PMID: 29173883 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters